Summary

Global Microcarrier Market Analysis

Global microcarrier market will reach US$ 1.91 billion in 2022 to US$ 4. 07 billion by 2032, with a compound annual growth rate of 8.87% from 2024 to 2032. Some of the factors which are driving the growth of this market are; cell culture technique improvements, growth in demand for cell culture derived vaccines, and rising investment being made in the biopharmaceuticals industry.


Microcarrier outlooks

Microcarriers are small, bead or particle like structures onto which cells of importance for tissue adhesion and growth in bioreactors are firmly attached. These particles usually consist of dextran, glass, or polystyrene which foster cell growth in a micro-environment. In connection with the utility of microcarriers for cell cultures, it should be noted that these structures are used more and more actively in the biotechnological and pharmaceutical industries because they increase the productivity and efficiency of cell cultures.

Some of the uses of microcarriers include preparing vaccines where the need to support large cell growth that is required for viral replication is felt. Biologics such as, monoclonal antibodies and therapeutic proteins are also produced with their help. In regenerative medicine, seeding and culture of cells on microcarriers is essential for the expansion of stem cells and other cell types used in tissue engineering or cell therapy. Their application in the areas of operation promotes mass production of cells that is vital in the advancement of health and Biotechnology.


Driving Forces for the Microcarrier Market

Advancements in Cell Culture Technology

Constant evolutions in cell culture technology have also greatly boosted the growth of the microcarrier market. New approaches to the bioreactors’ design, the culture media, and modifications of the microcarrier surface improve the cell cultures in terms of efficiency and reproducibility. Such advances in technology help to improve the cell attachment, growth and rates of proliferation thus boosting production. Moreover, there is progress in automation and those systems that control the process of cell culture, which makes the functioning of facilities more efficient, cuts the personnel expenses, and eliminates mistakes. These developments enhance the productivity and quality of cell-based products and facilitate scaling of cell culture, driving increased need for microcarriers in applications, such as in vaccines and biotherapeutic manufacturing and in regenerative medicine.


Increasing Demand for Cell-Based Vaccines

Increasing trends of infectious diseases and the requirement of cell-based vaccines, in turn, necessitating microcarrier growth, and stimulating the growth of the microcarrier market. Compared to the egg-based vaccine production methods, Production using cells eliminate the constraints that come with outbreaks for instance by being faster and more flexible. Microcarriers enables cultivation of adherent cells needed for virus production hence necessary in vaccines production. The readiness for production increasing as response to the new emerging infectious diseases’ strains is a very strong benefit therefore microcarriers become the key components of the modern vaccine production. Cultivated vaccines tend to refer higher yields and better uniformity, thus boosting the use of cell-based vaccines and, consequently, the market demand.


Expanding Applications in Regenerative Medicine and Cell Therapy

The microcarrier market is fueled by the emergent new industries of regenerative medicine and cell therapy. These medical disciplines require a vast number of stem cells and other adherent cell types for treatments that can restore or replace the lost or damaged tissues as well as cure several diseases. Microcarriers are suitable for the growth and differentiation of these cells and thus suitable for clinical advances. The applicative growth of clinical trials and registration approvals of cell-based therapies also contributes significantly to the call for efficient and affordable cell culturing. Thus, as the regenerative medicine and cell therapy expand and move to the regular application, the specifically organized microcarriers can provide the base for the high-quality and high-volume cell generation.


Rising Investments in Biopharmaceutical Research and Development

Lifesciences and more specifically, escalating research and development in processes of Biopharmaceutical R & D is contributing tremendously to the enhanced growth of the microcarrier. In this regard, marketing growth is stimulated by biopharmaceutical companies that are always in search of new solutions to improve production. The constant emphasis on new and technologically progressive biotherapeutics &, better manufacturing processes ensure the continuous demand for microcarriers, thus paving the market’s way.


Asia Pacific Microcarrier Market

Currently, the Asia Pacific microcarrier market is on the right Track due to the following reasons. Another factor that contributes to the growth in demand for microcarriers is the growth of the area’s biopharmaceutical sector as well as a higher interest in investment in biotech and life sciences research. Areas such as China, Indian, and Japan specifically leading the pack due to the solid backing from their governments, and bullish policies in place for promoting the growth in biomanufacturing. Also, higher incidences of chronic diseases and the desire for better treatment types such as cell-based vaccines, regenerative medicine act as another factor that boosts the growth of the global biological market. The accessibility of a robust workforce, economical manufacturing processes, and the setting up of several biotech centers also help to increase a rate of growth of the microcarrier market in the Asia Pacific region.


Microcarrier Company Analysis

The microcarrier industry leader are Thermo Fisher Scientific, Eppendorf AG, Danaher Corporation, Sartorius AG, Bio-Rad Laboratories, Inc, Corning Inc, Lonza Group, Getinge and Becton, Dickinson and Company. These companies are generally recognized as specialists in the manufacturing of excellent microcarriers for use in cell culturing.


Product– Market breakup in 2 viewpoints:

Consumables

1. Microcarrier Beads
2. Media & Reagents

Equipment

Application– Market breakup in 3 viewpoints:

1. Cell Therapy
2. Vaccine Manufacturing
3. Others


End User– Market breakup in 3 viewpoints:

1. Pharmaceutical & Biotechnology Companies
2. Contract Research Organizations & Contract Manufacturing Organizations
3. Academic & Research Institutes


Country – Market breakup of 25 Countries:

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherland
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

Rest of the world


All the key players have been covered from 4 Viewpoints:

• Business Overview
• Product Portfolio
• Recent Development & Strategies
• Revenue Analysis


Key Players Analysis:

1. Thermo Fisher Scientific
2. Merck KGaA
3. Eppendorf AG
4. Danaher Corporation
5. Sartorius AG
6. Bio-Rad Laboratories, Inc.
7. Corning Inc.
8. Lonza Group
9. Getinge
10. Becton, Dickinson and Company

ページTOPに戻る

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. Global Microcarriers Market

6. Global Microcarriers Market – Share Analysis

6.1 By Product Type

6.1.1 By Consumables

6.2 By Application
6.3 By End User
6.4 By Countries


7. Product Type

7.1 Consumables

7.1.1 Microcarrier Beads
7.1.2 Media & Reagents

7.2 Equipment


8. Application

8.1 Cell Therapy
8.2 Vaccine Manufacturing
8.3 Others


9. End User

9.1 Pharmaceutical & Biotechnology Companies
9.2 Contract Research Organizations & Contract Manufacturing Organizations
9.3 Academic & Research Institutes


10. Countries

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherland

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Thailand
10.3.7 Malaysia
10.3.8 Indonesia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 Turkey
10.5.4 UAE

10.6 Rest of the World


11. Porter’s Five Forces Analysis

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Key Players Analysis

13.1 Thermo Fisher Scientific

13.1.1 Overview
13.1.2 Product Portfolio
13.1.3 Recent Development
13.1.4 Revenue Analysis

13.2 Merck KGaA

13.2.1 Overview
13.2.2 Product Portfolio
13.2.3 Recent Development
13.2.4 Revenue Analysis

13.3 Eppendorf AG

13.3.1 Overview
13.3.2 Product Portfolio
13.3.3 Recent Development
13.3.4 Revenue Analysis

13.4 Danaher Corporation

13.4.1 Overview
13.4.2 Product Portfolio
13.4.3 Recent Development
13.4.4 Revenue Analysis

13.5 Sartorius AG

13.5.1 Overview
13.5.2 Product Portfolio
13.5.3 Recent Development
13.5.4 Revenue Analysis

13.6 Bio-Rad Laboratories, Inc.

13.6.1 Overview
13.6.2 Recent Development & Strategies
13.6.3 Revenue Analysis

13.7 Corning Inc.

13.7.1 Overview
13.7.2 Product Portfolio
13.7.3 Recent Development
13.7.4 Revenue Analysis

13.8 Lonza Group

13.8.1 Overview
13.8.2 Product Portfolio
13.8.3 Recent Development
13.8.4 Revenue Analysis

13.9 Getinge

13.9.1 Overview
13.9.2 Product Portfolio
13.9.3 Recent Development
13.9.4 Revenue Analysis

13.10 Becton, Dickinson and Company

13.10.1 Overview
13.10.2 Product Portfolio
13.10.3 Recent Development
13.10.4 Revenue Analysis